A study of the probit model with latent variables in Phase I clinical trials (Q5220814): Difference between revisions
From MaRDI portal
Changed an Item |
Set profile property. |
||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: Publication / rank | |||
Normal rank | |||
Revision as of 19:20, 5 March 2024
scientific article; zbMATH DE number 7183154
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A study of the probit model with latent variables in Phase I clinical trials |
scientific article; zbMATH DE number 7183154 |
Statements
A study of the probit model with latent variables in Phase I clinical trials (English)
0 references
27 March 2020
0 references
Bayesian method
0 references
continual reassessment method
0 references
dose finding
0 references
latent variable
0 references
Markov chain Monte Carlo
0 references
phase I clinical trial
0 references
probit model
0 references
